Revision of the Dissolution Procedure: Development and Validation <1092>

被引：1
|
作者：
Skwierczynski, R. [1 ]
Curry, P.
Gray, V.
Kraemer, J.
Stippler, E.
Suggett, J.
Mirza, T. [1 ]
Brown, W. [1 ]
机构：
[1] US Pharmacopeial Convent Inc, Rockville, MD 20852 USA
来源：
DISSOLUTION TECHNOLOGIES | 2014年 / 21卷 / 01期
关键词：
D O I：
10.14227/DT210114P6
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
In this Stimuli article a Subcommittee of the Pharmaceutical Dosage Forms Expert Committee discusses a proposed revision to general information chapter The Dissolution Procedure: Development and Validation < 1092 >. Published elsewhere in this issue of PF, the proposed revision provides a new structure that divides the process of development and validation of the dissolution test into its component parts. The revision adds sections about preliminary assessments needed before initiating method development and about automation. A new section, Interpretation, within Acceptance Criteria clarifies the interpretation of results from the dissolution test. The relationship between bioavailability, bioequivalence, and the dissolution test is considered in general chapter Assessment of Drug Product Performance-Bioavailability, Bioequivalence, and Dissolution < 1090 >.
引用
收藏
页码：6 / 8
页数：3
相关论文
共 50 条
  • [41] DISSOLUTION METHOD DEVELOPMENT AND VALIDATION OF EPLERENONE TABLETS BY UV SPECTROPHOTOMETRY
    Shaniya, P.
    Hepsebah, N. J. R.
    Khasim, M. D.
    Kumar, A. Ashok
    [J]. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 3 (04): : 351 - 357
  • [42] Development and Validation of a Dissolution Test Method for Artemether and Lumefantrine in Tablets
    Umapathi, P.
    Ayyappan, J.
    Quine, S. Darlin
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2011, 10 (05) : 643 - 653
  • [43] Dissolution study of capsules containing itraconazol: Method development and validation
    Martinello, Valeska C. A.
    Serra, Cristina H. R.
    [J]. LATIN AMERICAN JOURNAL OF PHARMACY, 2008, 27 (01): : 93 - 99
  • [44] The estimation and use of measurement uncertainty for a drug substance test procedure validated according to USP &lt;1225&gt;
    Weitzel, M. L. Jane
    [J]. ACCREDITATION AND QUALITY ASSURANCE, 2012, 17 (02) : 139 - 146
  • [45] Development and validation methodology of the Nuss procedure surgical planner
    Rechowicz, Krzysztof J.
    McKenzie, Frederic D.
    [J]. SIMULATION-TRANSACTIONS OF THE SOCIETY FOR MODELING AND SIMULATION INTERNATIONAL, 2013, 89 (12): : 1474 - 1488
  • [46] Development and validation of a procedure of seismic performance evaluation of structures
    Ayala, A. G.
    Mendoza, M.
    Apostolska, R.
    [J]. COST ACTION C26: URBAN HABITAT CONSTRUCTIONS UNDER CATASTROPHIC EVENTS, 2010, : 541 - 546
  • [47] GT36 TURBINE AERO-THERMAL DEVELOPMENT AND VALIDATION
    Naik, S.
    Krueckels, J.
    Henze, M.
    Hofmann, W.
    Schnieder, M.
    [J]. PROCEEDINGS OF THE ASME TURBO EXPO: TURBINE TECHNICAL CONFERENCE AND EXPOSITION, 2017, VOL 3, 2017,
  • [48] GT36 TURBINE DEVELOPMENT AND FULL-SCALE VALIDATION
    Naik, S.
    Stephan, B.
    Henze, M.
    [J]. PROCEEDINGS OF ASME TURBO EXPO 2021: TURBOMACHINERY TECHNICAL CONFERENCE AND EXPOSITION, VOL 4, 2021,
  • [49] Dissolution Method for Milnacipran Hydrochloride Capsules: Development, Validation, and Study of Changes in Dissolution Rate after Storage
    Dias, Carolina Lupi
    Rossi, Rochele Cassanta
    Bajerski, Lisiane
    Froeehlich, Pedro Eduardo
    [J]. DISSOLUTION TECHNOLOGIES, 2011, 18 (03): : 47 - 53
  • [50] Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets
    Breier, AR
    Paim, CS
    Steppe, M
    Schapoval, EES
    [J]. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2005, 8 (02): : 289 - 298
12345